California State Teachers Retirement System (CalSTRS)
ABUS icon

California State Teachers Retirement System (CalSTRS)’s Arbutus Biopharma ABUS Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$643K Sell
142,985
-1,125
-0.8% -$4.92K ﹤0.01% 1975
2025
Q4 		$693K Buy
144,110
+12,642
+10% +$56.8K ﹤0.01% 1955
2025
Q3 		$597K Sell
131,468
-1,290
-1% -$4.74K ﹤0.01% 2015
2025
Q2 		$410K Hold
132,758
– – ﹤0.01% 2126
2025
Q1 		$463K Hold
132,758
– – ﹤0.01% 2084
2024
Q4 		$434K Sell
132,758
-1,512
-1% -$5.56K ﹤0.01% 2168
2024
Q3 		$517K Buy
134,270
+124,163
+1,228% +$476K ﹤0.01% 2107
2024
Q2 		$31.2K Sell
10,107
-2,630
-21% -$7.89K ﹤0.01% 2470
2024
Q1 		$32.9K Sell
12,737
-8,117
-39% -$21K ﹤0.01% 2572
2023
Q4 		$52.1K Sell
20,854
-6,687
-24% -$13.1K ﹤0.01% 2590
2023
Q3 		$55.9K Sell
27,541
-13,980
-34% -$29.3K ﹤0.01% 2673
2023
Q2 		$95.5K Sell
41,521
-719
-2% -$1.87K ﹤0.01% 2663
2023
Q1 		$128K Sell
42,240
-3,924
-9% -$11.1K ﹤0.01% 2645
2022
Q4 		$108K Buy
46,164
+3,538
+8% +$8.46K ﹤0.01% 2747
2022
Q3 		$81K Sell
42,626
-3,554
-8% -$8.37K ﹤0.01% 2872
2022
Q2 		$125K Buy
46,180
+7,475
+19% +$19.1K ﹤0.01% 2799
2022
Q1 		$115K Sell
38,705
-4,886
-11% -$15K ﹤0.01% 2820
2021
Q4 		$170K Buy
43,591
+1,428
+3% +$5.55K ﹤0.01% 2841
2021
Q3 		$181K Sell
42,163
-65,930
-61% -$220K ﹤0.01% 2779
2021
Q2 		$328K Buy
+108,093
New +$335K ﹤0.01% 2865
2019
Q2 		– Sell
-54,700
Closed -$196K – 3027
2019
Q1 		$196K Sell
54,700
-6,924
-11% -$26.6K ﹤0.01% 2763
2018
Q4 		$236K Buy
61,624
+7,230
+13% +$35.6K ﹤0.01% 2684
2018
Q3 		$514K Buy
54,394
+357
+0.7% +$3.54K ﹤0.01% 2438
2018
Q2 		$394K Buy
+54,037
New +$322K ﹤0.01% 2582

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s ABUS Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Arbutus Biopharma (ABUS) stake by 0.78% in Q1 2026, selling an estimated $4.92K and leaving 142,985 shares worth $643K. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

California State Teachers Retirement System (CalSTRS) first reported a position in ABUS in Q2 2018 and has held it in 24 quarters since. The position peaked at $693K in Q4 2025. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 142,985 shares of Arbutus Biopharma worth $643K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 1,125 Arbutus Biopharma shares in Q1 2026, an estimated $4.92K.
  • Arbutus Biopharma made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1975 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Arbutus Biopharma in Q2 2018 and has held it in 24 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Arbutus Biopharma position peaked at $693K in Q4 2025.
  • 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.